Noah Berlow received his PhD in electrical engineering following undergraduate studies in electrical engineering, computer science, and mathematics. His graduate work grew into a long-term collaboration with Dr. Charles Keller, then at Oregon Health & Sciences University. Upon graduating, he joined the non-profit mission-based biotech start-up, the Children’s Cancer Therapy Development Institute as a postdoctoral fellow in bioinformatics and molecular biology, with the goal of turning his research on personalized combination cancer therapy into a clinical tool to help cancer patients in need. This goal became his own start-up, First Ascent Biomedical, with the mission of making combination cancer therapy rapid, affordable, and personalized to the individual patient.
“No one should ever run out of options in the fight against cancer.”–Noah Berlow Ph. D
